The Global Medical Excellence Lead is an Associate Director-level leader embedded within Germany, operating at the intersection of Global Medical Excellence direction and in-market execution. Germany is one of the Core Markets in the IBU. The six markets, UK, Germany, Canada, Brazil, China, and Japan, represent the majority of IBU business and are the most strategically important markets for Takeda’s portfolio and launch agenda. Carrying a global mandate and reporting directly to the Head, Global Medical Excellence, this role carries a high strategic weight, and the individual is expected to contribute not only to in-market execution but to the broader Global Medical Excellence agenda.
The role serves as the day-to-day capability partner for Germany, building the relationships, programmes, and capability foundations that enable the Medical team to perform at their best through trusted peer-level partnerships with the Country Medical Director and Country GM. Working closely with IBU Medical Excellence & Operations, Marketing & Commercial Excellence, and the Global Scientific Training team, this role ensures capability development, onboarding, field medical effectiveness, and launch readiness are coherent and additive for the country Medical team, while feeding local insight back to shape global programming.
Note on OBU markets: In markets where the Oncology Business Unit operates, including UK, Germany, and Japan, dual Medical teams exist in-country under separate reporting lines. The Global Medical Excellence Lead navigates this complexity by building relationships with both the IBU and OBU Medical teams in-country, ensuring capability development and Medical Excellence standards are consistent across both structures.